News and Press
Bourne Partners Advises and Invests in the Acquisition of Five Pharmaceutical Brands from GSK - 12/22/11
ZUG Switzerland (December 22, 2011) - Covis Pharma Sàrl (“Covis Pharma”), a Switzerland-based specialty pharmaceutical company owned by affiliates of Cerberus Capital Manageme
Theramed Corporation to launch Glenveigh Products, ebb™ and jetty™ at The Society of Obstetricians and Gynecologists of Canada - 7/14/2011
Mississauga, ON, Canada
Theramed Corporation(“Theramed”) announces that it will launch ebb™ and je
Theramed Corporation Adds New Territory Manager to Expand Presence in Western Canada - 6/13/2011
Mississauga, ON, Canada – Theramed adds new territory manager Alan Mills. Mr. Mills will be responsible for sales in Western Canada and will be based in C
Theramed Secures Exclusive Canadian Distribution Rights For Two Novel Obstetrics Products from Glenveigh - 4/7/2011
Mississauga, ON, Canada
Theramed Corporation (“Theramed”)
Pinnacle Biologics Acquires PHOTOFRIN® and PHOTOBARR®, Novel Photodynamic Therapy for Treating Various Types of Cancer - 3/29/2011
BANNOCKBURN, IL--(Marketwire - March 29, 2011) - Pinnacle Biologics, Inc., a privately held specialty bio-pharmaceutical company announced today the global acquisition of PHOTOFRIN® and PHOT
Sumavel DosePro is Granted First European Approval - 12/7/2010
Zogenix, Inc. (“Zogenix”, Nasdaq:ZGNX) and Desitin Pharmaceuticals GmbH (“Desitin”) today anounced that they were granted approval of the Marketing Authorization Applicat
Theramed Corporation Signs Extension with EUSA Pharma Ltd. (issued by portfolio company) - 8/5/2010
Theramed Corporation signs an eight year extension with EUSA Pharma Ltd. for the exclusive right to import, market and distribute COLL
Theramed Announces the Re-launch of Web Site Informing Canadians about Tick-Borne Encephalitis - 8/9/2010
MISSISSAUGA, ON, Canada and CAMBRIDGE, MA, USA—August 9, 2010—Theramed Corporation and Body1, Inc. announce the re-launch of a novel web site informing Canadians about Tick-Borne Enc
|
